| Literature DB >> 32219926 |
Adebayo Shittu1,2, Stefanie Deinhardt-Emmer3, Jonathan Vas Nunes4,5, Silke Niemann2, Martin P Grobusch5,6, Frieder Schaumburg2.
Abstract
Tropical pyomyositis (TP) is a life-threatening bacterial infection of the skeletal muscle that occurs particularly among children, young adults and those with immunocompromised conditions. The appropriate diagnosis and treatment are often delayed due to its non-specific signs, leading to fatal consequences. Staphylococcus aureus, especially methicillin-susceptible S. aureus, is responsible for most TP cases. However, other bacteria (i.e. streptococci, Pseudomonas aeruginosa, Escherichia coli, Klebsiella spp., Candida spp., Mycobacterium spp.) have been reported. This narrative review provides an update on the epidemiology and clinical course of TP. A special focus is laid on the role of toxins (i.e. Panton-Valentine Leucocidin and α-toxin) in the pathogenesis of TP and their implication for the clinical management of infection.Entities:
Keywords: zzm321990Staphylococcus aureuszzm321990; Staphylococcus aureus; clinical course; epidemiology; pathogenesis; pathogenèse; pyomyosite tropicale; review; revue; tropical pyomyositis; épidémiologie; évolution clinique
Year: 2020 PMID: 32219926 DOI: 10.1111/tmi.13395
Source DB: PubMed Journal: Trop Med Int Health ISSN: 1360-2276 Impact factor: 2.622